Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.

Identifieur interne : 001F76 ( PubMed/Corpus ); précédent : 001F75; suivant : 001F77

Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.

Auteurs : Chad M. Petit ; Vladimir N. Chouljenko ; Arun Iyer ; Robin Colgrove ; Michael Farzan ; David M. Knipe ; K G Kousoulas

Source :

RBID : pubmed:17134730

English descriptors

Abstract

The SARS-coronavirus (SARS-CoV) is the etiological agent of the severe acute respiratory syndrome (SARS). The SARS-CoV spike (S) glycoprotein mediates membrane fusion events during virus entry and virus-induced cell-to-cell fusion. The cytoplasmic portion of the S glycoprotein contains four cysteine-rich amino acid clusters. Individual cysteine clusters were altered via cysteine-to-alanine amino acid replacement and the modified S glycoproteins were tested for their transport to cell-surfaces and ability to cause cell fusion in transient transfection assays. Mutagenesis of the cysteine cluster I, located immediately proximal to the predicted transmembrane, domain did not appreciably reduce cell-surface expression, although S-mediated cell fusion was reduced by more than 50% in comparison to the wild-type S. Similarly, mutagenesis of the cysteine cluster II located adjacent to cluster I reduced S-mediated cell fusion by more than 60% compared to the wild-type S, while cell-surface expression was reduced by less than 20%. Mutagenesis of cysteine clusters III and IV did not appreciably affect S cell-surface expression or S-mediated cell fusion. The wild-type S was palmitoylated as evidenced by the efficient incorporation of (3)H-palmitic acid in wild-type S molecules. S glycoprotein palmitoylation was significantly reduced for mutant glycoproteins having cluster I and II cysteine changes, but was largely unaffected for cysteine cluster III and IV mutants. These results show that the S cytoplasmic domain is palmitoylated and that palmitoylation of the membrane proximal cysteine clusters I and II may be important for S-mediated cell fusion.

DOI: 10.1016/j.virol.2006.10.034
PubMed: 17134730

Links to Exploration step

pubmed:17134730

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.</title>
<author>
<name sortKey="Petit, Chad M" sort="Petit, Chad M" uniqKey="Petit C" first="Chad M" last="Petit">Chad M. Petit</name>
<affiliation>
<nlm:affiliation>Division of Biotechnology and Molecular Medicine (BIOMMED), USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chouljenko, Vladimir N" sort="Chouljenko, Vladimir N" uniqKey="Chouljenko V" first="Vladimir N" last="Chouljenko">Vladimir N. Chouljenko</name>
</author>
<author>
<name sortKey="Iyer, Arun" sort="Iyer, Arun" uniqKey="Iyer A" first="Arun" last="Iyer">Arun Iyer</name>
</author>
<author>
<name sortKey="Colgrove, Robin" sort="Colgrove, Robin" uniqKey="Colgrove R" first="Robin" last="Colgrove">Robin Colgrove</name>
</author>
<author>
<name sortKey="Farzan, Michael" sort="Farzan, Michael" uniqKey="Farzan M" first="Michael" last="Farzan">Michael Farzan</name>
</author>
<author>
<name sortKey="Knipe, David M" sort="Knipe, David M" uniqKey="Knipe D" first="David M" last="Knipe">David M. Knipe</name>
</author>
<author>
<name sortKey="Kousoulas, K G" sort="Kousoulas, K G" uniqKey="Kousoulas K" first="K G" last="Kousoulas">K G Kousoulas</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17134730</idno>
<idno type="pmid">17134730</idno>
<idno type="doi">10.1016/j.virol.2006.10.034</idno>
<idno type="wicri:Area/PubMed/Corpus">001F76</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F76</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.</title>
<author>
<name sortKey="Petit, Chad M" sort="Petit, Chad M" uniqKey="Petit C" first="Chad M" last="Petit">Chad M. Petit</name>
<affiliation>
<nlm:affiliation>Division of Biotechnology and Molecular Medicine (BIOMMED), USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chouljenko, Vladimir N" sort="Chouljenko, Vladimir N" uniqKey="Chouljenko V" first="Vladimir N" last="Chouljenko">Vladimir N. Chouljenko</name>
</author>
<author>
<name sortKey="Iyer, Arun" sort="Iyer, Arun" uniqKey="Iyer A" first="Arun" last="Iyer">Arun Iyer</name>
</author>
<author>
<name sortKey="Colgrove, Robin" sort="Colgrove, Robin" uniqKey="Colgrove R" first="Robin" last="Colgrove">Robin Colgrove</name>
</author>
<author>
<name sortKey="Farzan, Michael" sort="Farzan, Michael" uniqKey="Farzan M" first="Michael" last="Farzan">Michael Farzan</name>
</author>
<author>
<name sortKey="Knipe, David M" sort="Knipe, David M" uniqKey="Knipe D" first="David M" last="Knipe">David M. Knipe</name>
</author>
<author>
<name sortKey="Kousoulas, K G" sort="Kousoulas, K G" uniqKey="Kousoulas K" first="K G" last="Kousoulas">K G Kousoulas</name>
</author>
</analytic>
<series>
<title level="j">Virology</title>
<idno type="ISSN">0042-6822</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Fusion</term>
<term>Cell Membrane (chemistry)</term>
<term>Chlorocebus aethiops</term>
<term>Cysteine (genetics)</term>
<term>Cysteine (physiology)</term>
<term>Immunohistochemistry</term>
<term>Isotope Labeling</term>
<term>Membrane Fusion</term>
<term>Membrane Glycoproteins (chemistry)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Molecular Sequence Data</term>
<term>Mutagenesis, Site-Directed</term>
<term>Palmitic Acid (analysis)</term>
<term>Palmitic Acid (metabolism)</term>
<term>Protein Processing, Post-Translational</term>
<term>SARS Virus (chemistry)</term>
<term>SARS Virus (physiology)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Tritium (metabolism)</term>
<term>Vero Cells</term>
<term>Viral Envelope Proteins (chemistry)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Palmitic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Cysteine</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Cell Membrane</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Palmitic Acid</term>
<term>Tritium</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Cysteine</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Fusion</term>
<term>Chlorocebus aethiops</term>
<term>Immunohistochemistry</term>
<term>Isotope Labeling</term>
<term>Membrane Fusion</term>
<term>Molecular Sequence Data</term>
<term>Mutagenesis, Site-Directed</term>
<term>Protein Processing, Post-Translational</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vero Cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The SARS-coronavirus (SARS-CoV) is the etiological agent of the severe acute respiratory syndrome (SARS). The SARS-CoV spike (S) glycoprotein mediates membrane fusion events during virus entry and virus-induced cell-to-cell fusion. The cytoplasmic portion of the S glycoprotein contains four cysteine-rich amino acid clusters. Individual cysteine clusters were altered via cysteine-to-alanine amino acid replacement and the modified S glycoproteins were tested for their transport to cell-surfaces and ability to cause cell fusion in transient transfection assays. Mutagenesis of the cysteine cluster I, located immediately proximal to the predicted transmembrane, domain did not appreciably reduce cell-surface expression, although S-mediated cell fusion was reduced by more than 50% in comparison to the wild-type S. Similarly, mutagenesis of the cysteine cluster II located adjacent to cluster I reduced S-mediated cell fusion by more than 60% compared to the wild-type S, while cell-surface expression was reduced by less than 20%. Mutagenesis of cysteine clusters III and IV did not appreciably affect S cell-surface expression or S-mediated cell fusion. The wild-type S was palmitoylated as evidenced by the efficient incorporation of (3)H-palmitic acid in wild-type S molecules. S glycoprotein palmitoylation was significantly reduced for mutant glycoproteins having cluster I and II cysteine changes, but was largely unaffected for cysteine cluster III and IV mutants. These results show that the S cytoplasmic domain is palmitoylated and that palmitoylation of the membrane proximal cysteine clusters I and II may be important for S-mediated cell fusion.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17134730</PMID>
<DateCompleted>
<Year>2007</Year>
<Month>06</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0042-6822</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>360</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2007</Year>
<Month>Apr</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>Virology</Title>
<ISOAbbreviation>Virology</ISOAbbreviation>
</Journal>
<ArticleTitle>Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.</ArticleTitle>
<Pagination>
<MedlinePgn>264-74</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The SARS-coronavirus (SARS-CoV) is the etiological agent of the severe acute respiratory syndrome (SARS). The SARS-CoV spike (S) glycoprotein mediates membrane fusion events during virus entry and virus-induced cell-to-cell fusion. The cytoplasmic portion of the S glycoprotein contains four cysteine-rich amino acid clusters. Individual cysteine clusters were altered via cysteine-to-alanine amino acid replacement and the modified S glycoproteins were tested for their transport to cell-surfaces and ability to cause cell fusion in transient transfection assays. Mutagenesis of the cysteine cluster I, located immediately proximal to the predicted transmembrane, domain did not appreciably reduce cell-surface expression, although S-mediated cell fusion was reduced by more than 50% in comparison to the wild-type S. Similarly, mutagenesis of the cysteine cluster II located adjacent to cluster I reduced S-mediated cell fusion by more than 60% compared to the wild-type S, while cell-surface expression was reduced by less than 20%. Mutagenesis of cysteine clusters III and IV did not appreciably affect S cell-surface expression or S-mediated cell fusion. The wild-type S was palmitoylated as evidenced by the efficient incorporation of (3)H-palmitic acid in wild-type S molecules. S glycoprotein palmitoylation was significantly reduced for mutant glycoproteins having cluster I and II cysteine changes, but was largely unaffected for cysteine cluster III and IV mutants. These results show that the S cytoplasmic domain is palmitoylated and that palmitoylation of the membrane proximal cysteine clusters I and II may be important for S-mediated cell fusion.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Petit</LastName>
<ForeName>Chad M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo>
<Affiliation>Division of Biotechnology and Molecular Medicine (BIOMMED), USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chouljenko</LastName>
<ForeName>Vladimir N</ForeName>
<Initials>VN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Iyer</LastName>
<ForeName>Arun</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Colgrove</LastName>
<ForeName>Robin</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Farzan</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Knipe</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kousoulas</LastName>
<ForeName>K G</ForeName>
<Initials>KG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2006</Year>
<Month>11</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Virology</MedlineTA>
<NlmUniqueID>0110674</NlmUniqueID>
<ISSNLinking>0042-6822</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>10028-17-8</RegistryNumber>
<NameOfSubstance UI="D014316">Tritium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2V16EO95H1</RegistryNumber>
<NameOfSubstance UI="D019308">Palmitic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K848JZ4886</RegistryNumber>
<NameOfSubstance UI="D003545">Cysteine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002459" MajorTopicYN="Y">Cell Fusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007553" MajorTopicYN="N">Isotope Labeling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008561" MajorTopicYN="Y">Membrane Fusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019308" MajorTopicYN="N">Palmitic Acid</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011499" MajorTopicYN="Y">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014316" MajorTopicYN="N">Tritium</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2006</Year>
<Month>06</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2006</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2006</Year>
<Month>10</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>12</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>6</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2006</Year>
<Month>12</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17134730</ArticleId>
<ArticleId IdType="pii">S0042-6822(06)00790-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.virol.2006.10.034</ArticleId>
<ArticleId IdType="pmc">PMC7103323</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Biochim Biophys Acta. 1989 Dec 6;988(3):411-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2686758</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell. 1998 Dec 23;95(7):871-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9875840</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 1990 May;176(1):296-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2184576</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Feb;80(3):1302-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16415007</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12746549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1984 Apr;81(7):2050-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6326102</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Oct;78(19):10328-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15367599</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proteomics. 2004 Feb;4(2):492-504</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14760722</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1992 Jun;66(6):3306-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1583717</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 1993 Sep;74 ( Pt 9):1981-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8376972</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Mol Biol. 1987 Aug 20;196(4):963-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3681988</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Res. 2004 Oct;14(5):400-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15450134</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2003 Jan;77(2):830-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12502799</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Cell Biol. 1987 Jun;104(6):1449-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3294853</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1992 Jun 4;357(6377):417-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1350661</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1948-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12748314</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Jun;78(11):5913-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15140989</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Methods Mol Biol. 1996;57:177-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8850005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Cell Biol. 1996 Oct;135(1):73-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8858164</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12927536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1998 Jan;72(1):133-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9420208</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1996 Mar;70(3):1406-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8627657</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1987 Mar 19-25;326(6110):309-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3821906</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 1993 Feb;74 ( Pt 2):183-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8381459</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2003 Jan;77(1):167-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12477822</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 1995 Jul 10;210(2):264-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7618266</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8709-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15161975</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem Soc Trans. 1995 Aug;23(3):565-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8566417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2005 Jun;79(11):7195-206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15890958</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 1987 Jul;68 ( Pt 7):1883-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3037011</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2003 Jan;77(2):841-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12502800</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Virol. 1987;95(1-2):123-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3036041</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2002 Sep 30;301(2):322-333</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12359434</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 1985 Apr;66 ( Pt 4):719-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2984314</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2000 Feb;74(3):1566-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10627571</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2000 Mar 30;269(1):212-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10725213</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 1993 Jul;195(1):195-202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8317096</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 1989 Dec;173(2):664-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2556846</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Cell Biol. 2000 Oct 16;151(2):413-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11038187</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9217-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15197264</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell. 1999 Mar;3(3):309-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10198633</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Sep;78(18):9904-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15331724</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1993 Aug;67(8):4504-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8392595</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1992 Dec;66(12):7585-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1433532</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1997 Dec;71(12):9427-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9371603</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 1990 May;71 ( Pt 5):1065-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2345367</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2006 Jan 5;344(1):38-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16364734</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioinformatics. 1998;14(4):378-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9632836</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>EMBO J. 2001 Aug 1;20(15):4024-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11483506</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1980 Jan;33(1):449-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6245243</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Proteomics. 2003 May;2(5):346-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12775768</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell. 2001 Apr 6;105(1):137-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11301009</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 1987 Dec;161(2):479-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2825419</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 1995 Dec 20;214(2):453-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8553547</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Mol Biol. 1981 Dec 25;153(4):993-1010</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7343686</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1994 Sep;68(9):5748-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8057456</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Annu Rev Biochem. 2001;70:777-810</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11395423</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2004 Oct 15;279(42):43661-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15304515</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2003 Aug;77(16):8801-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12885899</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1995 Nov;69(11):7045-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7474124</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2005 Oct 25;341(2):215-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16099010</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F76 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001F76 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:17134730
   |texte=   Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:17134730" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021